We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Sound Waves Separate Tumor and Blood Cells

By LabMedica International staff writers
Posted on 10 Sep 2014
Print article
Roche Diagnostic\'s BrdU Cell Proliferation enzyme-linked immunosorbent assay kit
The BrdU Cell Proliferation enzyme-linked immunosorbent assay kit (Photo courtesy of Roche Diagnostics)
A device has been developed that can test a cancer patient's blood for rare tumor cells and will be extremely useful for checking if a tumor is going to spread.

The relatively small device uses “tilted” sound waves, offering an effective way of sorting cells without having to treat them with chemicals or deform them mechanically. These sound waves cross the cells' trajectory at an angle instead of going straight across, ensuring that each cell encounters several low-pressure nodes on its journey through the microchannel instead of just one.

Scientists at the Pennsylvania State University (University Park, PA, USA) working with colleagues from other institutes developed a unique configuration of tilted-angle standing surface acoustic waves (taSSAW),which are oriented at an optimally designed inclination to the flow direction in the microfluidic channel. To optimize the device design, they carried out systematic simulations of cell trajectories, matching closely with experimental results.

In their study, the team first tested their device using plastic beads and showed it could separate beads of 9.9 micrometers from beads of 7.3 micrometers in diameter with around 97% accuracy. The team also tested how well the device was able to separate a human breast cancer epithelial cell line Michigan Cancer Foundation-7 (MCF-7) that are 20 micrometers diameter from white blood cells that are about 12 micrometers in diameter. The cells also differ by compressibility and density. The results showed the cell sorter recovered around 71% of the cancer cells. One of the tests used to test cell viability and proliferation was the BrdU Cell Proliferation enzyme-linked immunosorbent assay (Roche Diagnostics, Indianapolis, IN, USA).

The team now plans to test the 18 mm device with blood samples from cancer patients in clinical settings. Circulating tumor cells are very rare as 1 mL of a typical cancer patient's blood may only contain a few tumor cells. The scientists have filed for a patent on their device. They see it helping clinicians determine whether a patient's tumor is about to spread to other sites of the body as tumors that are about to metastasize begin to send out cells that travel through the bloodstream.

The authors concluded that the simple design, low cost, and standard fabrication process of the device allows for easy integration with other laboratory-on-a-chip technologies and small radio frequency (RF) power supplies to further develop a fully integrated cell separation and analysis system. The study was published on August 25, 2014, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:

Pennsylvania State University 
Roche Diagnostics 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.